About OrbitalRx
OrbitalRx is a private company based in Winston-Salem, North Carolina. It has reported $7,381,289 raised in seven offerings on Form D since May 2018. Its chief executive is Jason Gasper.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 26, 2025 | Oct 20, 2025 | $1,224,329of $2.5M target | 22 | $55,651 | EquityRule 506(b) | Form D ↗ |
| Jan 6, 2025 | Mar 5, 2025 | $958,932of $1.2M target | 18 | $53,274 | EquityRule 506(b) | Form D ↗ |
| May 26, 2023 | Oct 9, 2024 | $1,408,880of $1.5M target | 18 | $78,271 | EquityRule 506(b) | Form D ↗ |
| May 28, 2024 | Aug 9, 2024 | $855,701of $1.0M target | 17 | $50,335 | EquityRule 506(b) | Form D ↗ |
| Feb 14, 2020 | Feb 28, 2020amended Mar 2, 2020 | $733,481of $1.2M target | 7 | $104K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 1, 2018 | Oct 5, 2018amended Aug 29, 2019 | $2,149,966fully sold | 12 | $179K | EquityRule 504 | Form D/A ↗2 earlier filings |
| May 2, 2018 | May 10, 2018 | $50,000fully sold | 1 | $50,000 | OptionsRule 504 | Form D ↗ |
| Total, seven offerings | $7,381,289 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on OrbitalRx's Form D filed Oct 20, 2025.
Earlier filings also listed Nate Peaty (chief executive officer and director, last listed Mar 2025), Keith Heffron (executive officer, last listed Oct 2024), Mayank Thanawala (executive officer, last listed Mar 2020), David Carney (director, last listed Mar 2020) and Adam Orsborn (chief executive officer and director, last listed Mar 2020).